“Today we have very limited treatment options for stroke victims. For patients who arrive at the hospital more than four and a half hours after the stroke, there is actually no treatment available,” Professor Wieloch said.
An international clinical trial now underway on a Sigma-1 activator may eventually be used to help stroke victims recover cognitive and physical function more quickly. But Professor Wieloch underlines that it will not be a magic bullet able to instantly repair the brain. The rat study shows that rigorous therapies will still be required with the Sigma-1 stimulator, but that they may have better and more rapid results than without the drug.